We are thrilled to report that COLO-COHORT has officially recruited 4000 patients, doubling recruitment numbers from this time last year. COLO-COHORT Co-Chief Investigator, Prof Colin Rees, has expressed his delight...
We are very pleased to announce that we have completed recruitment to the COLO-DETECT trial. This is a brilliant achievement and we are very grateful to our sites for all...
The British Society of Gastroenterology (BSG) has featured Dr Laura Neilson in a masterclass video on their website looking at the importance of lesion detection and adenoma detection rate (ADR)...
In support of Colorectal Cancer Awareness Month, COLO-SPEED Chief Investigator, Prof. Colin Rees, and Lead Research Nurse, Ingrid Emmerson, have been featured on episode 9 of the Our People Podcast...
This year’s CPAW theme is to highlight the link between processed meat and bowel cancer – with their #SarnieSwap campaign encouraging people swap out the processed meat in their diet...
This week COLO-SPEED joins the Sir Bobby Robson Foundation, along with the wider football community, in the Bobby ’90 birthday tribute. Bobby ‘90 celebrates the life and legacy of Newcastle...
The December 2022 edition of the COLO-COHORT newsletter is now available online. Make sure to check it out for all the latest study news and an update on the upcoming IPAQ...
Parabola is a privately owned real estate development and investment group based in Edinburgh, Newcastle and London whose mission is to accommodate people and organisations in high-quality, safe, friendly and...
Newcastle University researchers in Gastroenterology and Hepatology are celebrating being ranked as top 10 in the latest US News Best Global Universities listing, conducted in collaboration with Clarivate. The league...
The September 2022 edition of the COLO-COHORT newsletter is now available online. Make sure to check it out for all the latest study news and updates as well as a...
We are very pleased to announce that COLO-COHORT has now surpassed its next major milestone of recruiting 3000 patients! Prof Colin Rees, COLO-COHORT Chief Investigator, has provided the following message...
We are delighted to announce that COLO-DETECT has now passed its second major milestone of recruiting 1000 patients into the trial and is now halfway to its target of 2000...
We are thrilled to announce that Prof. Colin Rees has been appointed as the new President Elect of the British Society of Gastroenterology (BSG). His term is set to run...
The first edition of the COLO-DETECT newsletter is now available online and has also been circulated to our study sites, stakeholders and subscribers. To stay up to speed with the...
The June 2022 edition of the COLO-COHORT newsletter is now available online and has also been circulated to our study sites, stakeholders and subscribers. Make sure to check it out...
The COLO-DETECT protocol paper has been published in Colorectal Disease. The paper is available to view online. For more on COLO-DETECT, please view the study page below.
We are very pleased to report that COLO-DETECT recently passed its first major milestone of recruiting 500 patients into the study! Since recruitment commenced in March 2021 at our sponsor...
We are thrilled to announce that we have received a prestigious funding award, from the National Institute of Health Research (NIHR), to examine the use of 'FIT' testing for people...
We are delighted to announce that COLO-COHORT has officially surpassed its next major milestone of recruiting 2000 patients! Recruitment rates have recovered well since re-opening the study after the peak...
The March 2022 edition of the COLO-COHORT newsletter is now available online and has also been circulated to our study sites, stakeholders and subscribers. Make sure to check it out...
The COLO-COHORT protocol paper has been published in Colorectal Disease. The paper is available to view online. For more on COLO-COHORT, please view the study page below.
The December 2021 edition of the COLO-COHORT newsletter has been circulated to our study sites and subscribers. If you would like to stay up to speed with the latest COLO-COHORT...
We are pleased to announce that COLO-COHORT has reached its next major milestone, with 1500 patients now recruited into the study! Recruitment figures have risen steadily during 2021, trebling since...
Work led by South Tyneside and Sunderland NHS Trust in collaboration with Newcastle University has delivered the world's first fully patient derived Experience Measure for Gastrointestinal Endoscopy. Previous measures have...
Paula Fowler, a patient who has played an integral role in patient and public involvement activities for COLO-SPEED, has been featured on the Chronicle Live website. In the article, Paula...
Guts UK are looking to appoint three volunteer Experts by Experience to sit on their Research Awards Committee. Experts by Experience (EBEs) are people who are living with a digestive...
COLO-COHORT has officially recruited its first 1000 patients, doubling the number of patients recruited into the study in just 4 months! We have seen a notable increase in recruitment rates...
Professor Mark Hull and colleagues are working to understand whether medicines such as aspirin, which reduce bowel polyps in the short-term, have prolonged benefit even after they have been stopped....
COLO-SPEED Chief Investigator, Prof. Colin Rees, has been announced as the winner of the prestigious British Society of Gastroenterologists (BSG) and National Institute of Health Research Clinical Research Network (NIHR...
Jennifer Smith, a COLO-COHORT participant who was recently recruited at South Tyneside and Sunderland NHS Foundation Trust, has been featured in an NIHR Clinical Research Network North East and North...
The May 2021 edition of the COLO-COHORT newsletter is now available. You can find the newsletter online if you would like to catch up on the latest COLO-COHORT news and...
COLO-SPEED team members from South Tyneside and Sunderland NHS Foundation Trust, Newcastle University and Leeds University have participated in the first ever Sir Bobby’s Football Run. The fundraising campaign, which...
All participants in the seAFOod Trial (see Participant Summary of Results) provided written informed consent for the STOP-ADENOMA team to obtain the results of future colonoscopy tests up to six...
We are very pleased to announce that COLO-COHORT has reached a major milestone with 500 patients now recruited into the study! We would like to extend a big thank you...
COLO-COHORT, a COLO-SPEED study, is committed to supporting and developing researchers of the future and is spearheading the NIHR Associate Principal Investigator (PI) Scheme for Gastroenterology. The scheme, which aims...
The COLO-DETECT study, which is looking at the ability of a new artificial intelligence device (GI Genius™) to help clinicians find polyps during a large bowel camera test (colonoscopy) –...
Mr Alexander Seager (Colorectal Surgical Trainee) has joined South Tyneside and Sunderland NHS Foundation Trust as a clinical research fellow to help deliver the COLO-DETECT study. COLO-DETECT is a clinical...
The November 2020 edition of the COLO-COHORT newsletter has been circulated to our study sites and subscribers. You can find the online version here if you would like to stay...
The COVID-19 pandemic has had a major impact upon society as a whole and this has affected medical research. COLO-SPEED, COLO-COHORT and associated studies had to pause recruitment of patients...
In a proof of concept study amongst healthy volunteers recruited at Newcastle University, FIT kits used in the bowel cancer screening programme were tested to assess suitability for testing the...
The COLO-SPEED (Colorectal Cancer Screening, Prevention, Endoscopy and Early Diagnosis) team recently won a prestigious patient care award for its world-leading endoscopy research. The team won the ‘Research’ category in...
A microbe is any living organism which is too tiny to be seen with the naked eye. It is also called a microorganism, or a microscopic organism. The major groups...
